CTCL in Patients Under 20 Years of Age: A Series of Five Cases

Patricia Rice Hickham , Elizabeth I. McBurney , Rebecca L. Fitzgerald
Pediatric Dermatology 14 ( 2) 93 -97

29
1997
ERBB2 EXPRESSION IN OESOPHAGEAL ADENOCARCINOMA AND BARRETT’S OESOPHAGUS: DEMONSTRATING THE POTENTIAL FOR A PRE-EMPTIVE STRIKE

SE Davies , RC Fitzgerald , M O Donovan , LB Lovat
In: GUT. (pp. A110 - A111). B M J PUBLISHING GROUP (2009)

2009
Relationship of COX-2 expression to gastrin and cell differentiation status in Barrett's esophagus and associated carcinoma

S Abdalla , RC Fitzgerald , M Novelli , P Lao-Sirieix
Clinical Cancer Research , 10 pp. 4784-4792. (2004)

2004
A biomarker study of lapatinib in the neoadjuvant treatment of HER2 over expressing esophago-gastric adenocarcinoma (EGA)

H Cheow , W Qain , M Jobanputra , RC Fitzgerald
In: (Proceedings) 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR). AMER ASSOC CANCER RESEARCH (2015)

2015
Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.

M Barber , A Murrell , Y Ito , A-T Maia
The Journal of Pathology 216 ( 3) 295 -306

99
2008
OC-040 First in-vivo study on the use of lectin-based molecular imaging in barrett’s oesophagus

M Di Pietro , E Bird-Lieberman , T Nuckcheddy-Grant , I Debiram
Gut 64

2015
Barrett metaplasia: reassessment of treatment and follow-up.

RC Fitzgerald
Current Opinion in Oncology 16 ( 4) 372 -377

4
2004
Immediate and early gene response to in vitro acid exposure in a Barrett’s adenocarcinoma cell line

C Morgan , W Alazawi , P Sirieix , N Freeman
Gut 52 ( Suppl 1) A44 -A44

6
2003
Detoxification loss drives aldehydemetabolic reprogramming and contributes to genotoxicity in oesophageal adenocarcinoma

S Antonowicz , Z Bodai , T Wiggins , S Markar
BRITISH JOURNAL OF SURGERY 104 46 -46

2017
Novel genomic aberrations in oesophagogastric cancer

JR Rees , S Chin , JC Marioni , C Caldas
GUT 56 A73 -A74

2007